SCHEMBL13838609

SCHEMBL13838609

C=C(/C=C(/C)ON)Oc1ccc(CC)c(-c2ccc(NC(=O)C3=CN=CCC3C)nc2)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13838459 0.80 ABCB1 (0.36) —
SCHEMBL13838527 0.70 IL2 (0.36) —
SCHEMBL16677944 0.56 RAB9A (0.53) —
SCHEMBL13728018 0.55 DYRK1A (0.49) —
SCHEMBL1825278 0.53 ALDH1A1 (0.58) —
SCHEMBL24969499 0.52 KMT2A (0.60) —
SCHEMBL27448525 0.51 PTK2 (0.51) —
SCHEMBL28286246 0.51 PTK2 (0.54) —
SCHEMBL27418247 0.51 HCAR3 (0.55) —
SCHEMBL22193254 0.50 TDO2 (0.50) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012151355-A1 COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP. (US) 2012-11-08 — — WO disclosed
Send feedback